Invention Grant
![Substituted 8-[6-amino-3-pyridyl]xanthines](/docs/US/2012-09-04/US08258142B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted 8-[6-amino-3-pyridyl]xanthines
- Patent Title (中): 取代的8- [6-氨基-3-吡啶基]黄嘌呤
-
Application No.: US12967876Application Date: 2010-12-14
-
Publication No.: US08258142B2Publication Date: 2012-09-04
- Inventor: Guoquan Wang , Robert D. Thompson , Jayson M. Rieger
- Applicant: Guoquan Wang , Robert D. Thompson , Jayson M. Rieger
- Applicant Address: US VA Charlottesville
- Assignee: Dogwood Pharmaceuticals, Inc.
- Current Assignee: Dogwood Pharmaceuticals, Inc.
- Current Assignee Address: US VA Charlottesville
- Main IPC: C07D473/06
- IPC: C07D473/06 ; A61K31/522 ; A61P11/06 ; A61P27/02 ; A61P1/12 ; A61P37/08
![Substituted 8-[6-amino-3-pyridyl]xanthines](/abs-image/US/2012/09/04/US08258142B2/abs.jpg.150x150.jpg)
Abstract:
The present invention provides substituted 8-[6-amino-3-pyridyl]xanthines such as the following: and pharmaceutical compositions that are selective antagonists of A2B adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents.
Public/Granted literature
- US20110082139A1 SUBSTITUTED 8-[6-AMINO-3-PYRIDYL]XANTHINES Public/Granted day:2011-04-07
Information query
